AzurRx BioPharma, Inc. Recorded Big Gain
Tue, Jan 07, 2020 at 05:30 PM
AzurRx BioPharma, Inc. (AZRX:NASDAQ) shot up at $1.32, a gain of 25.7%. On Mon 06 Jan 20, AZRX:NASDAQ hit a New 2-Week Intraday Low of $0.98. The stock got featured on our News Catalysts scanner on Mon 06 Jan 20 at 09:13 AM in the 'MISCELLANEOUS' category. From Fri 13 Dec 19, the stock recorded 64.29% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About AzurRx BioPharma, Inc. (AZRX:NASDAQ)
AzurRx BioPharma Inc through its subsidiary is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its products under development includes MS1819 and AZ1101.
Top 10 Gainers:
- Genetic Technologies Limited (GENE:NASDAQ), 120%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 70.42%
- Camber Energy, Inc. (CEI:NYSEMKT), 41.55%
- Genprex, Inc. (GNPX:NASDAQ), 39.07%
- U.S. Energy Corp. (USEG:NASDAQ), 28.32%
- Apellis Pharmaceuticals, Inc. (APLS:NASDAQ), 28.29%
- Waitr Holdings Inc. (WTRH:NASDAQ), 27.77%
- Gulf Resources, Inc. (GURE:NASDAQ), 27.53%
- Apache Corporation (APA:NYSE), 26.79%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 25.71%